UVA Health's comprehensive Adult Congenital Heart Disease (ACHD) Program supports patients adults needing continuity of care.
Author: Luis Soler Rivera
Swapnil Sonkusare, PhD, focuses on how the breakdown of cellular communication in vascular walls can lead to cardiovascular disease.
With pulsed field ablation, afib patients have better outcomes thanks to its focused approach and our deep ablation expertise.
This GPS-like tool reduces fluoroscopy radiation and provides a 3D map of a patient's vasculature, so procedures are quicker and safer.
UVA Health researchers have developed new MRI techniques that measure epicardial adipose tissue makeup to help assess heart disease risk.
Kenneth Bilchick, MD, MS, researches AI tools for analyzing cardiac imaging data and how it may lead to personalized heart rhythm care.
We share important lessons about external iliac artery endofibrosis care gleaned from high-performance athletes that may impact all patients.
By impacting paracardiac fat and LV mass, GLP-1 tirzepatide has shown promise for improving obesity-related HFpEF.
Biomedical engineer Jeffrey Saucerman, PhD, uses cutting-edge techniques and technology to find new paths to future heart treatments.
See how we're improving outcomes and shortening hospital stays for open aortic aneurysm surgery patients with our new recovery program.